FOXM1 and hepatocellular carcinoma: Our previous study has demonstrated that treatment with histone deacetylase inhibitor (HDACi) suppressed FOXM1 expression and sensitized HCC cells to oxidative stress, which led to G2/M cell cycle arrest at a low level of oxidative stress 20.